장수환 (울산대학교 의과대학, 서울아산병원)님 | 한빛사연구자 > 한빛사

울산대학교 의과대학, 서울아산병원

최종업데이트 2025.12.04.

B cell-reactive neoantigens boost antitumor immunity
- Sci. Adv., Dec 05 2025, 11 (49) | https://doi.org/10.1126/sciadv.adx8303
- 2025-12
- 생명과학
- 한빛사논문
Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models.
- J. Control. Release, Available online 19 September 2022 | https://doi.org/10.1016/j.jconrel.2022.09.007
- 2022-09
- 바이오·의료융합
- 한빛사논문
Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis
- Proc. Natl. Acad. Sci. USA, July 18, 2022 119 (30) e2119048119 | https://doi.org/10.1073/pnas.2119048119
- 2022-07
- 의약학
- 한빛사논문
Aberrant transcript usage is associated with homologous recombination deficiency and predicts therapeutic response
- Cancer Res., Published first October 28, 2021 | DOI: 10.1158/0008-5472.CAN-21-2023
- 2021-10
- 생명과학
- 한빛사논문
The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
- Cancer Res. Treat., Volume 50, Issue 1, 1 January 2018, Pages 1-10 | https://doi.org/10.4143/crt.2017.307
- 2018-01
- 의약학
- 상위피인용논문
Computational inference of cancer-specific vulnerabilities in clinical samples
- Genome Biol., Published: 29 June 2020,21, Article number: 155 (2020) | https://doi.org/10.1186/s13059-020-02077-1
- 2020-06
- 생명과학
- 한빛사논문

연구자 ID

저자논문